These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11397121)
1. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. Goydos JS; Patel M; Shih W J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121 [TBL] [Abstract][Full Text] [Related]
2. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003 [TBL] [Abstract][Full Text] [Related]
3. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma. Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1. Vaughan HA; Svobodova S; Macgregor D; Sturrock S; Jungbluth AA; Browning J; Davis ID; Parente P; Chen YT; Stockert E; St Clair F; Old LJ; Cebon J Clin Cancer Res; 2004 Dec; 10(24):8396-404. PubMed ID: 15623618 [TBL] [Abstract][Full Text] [Related]
5. Tumor antigen expression in melanoma varies according to antigen and stage. Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087 [TBL] [Abstract][Full Text] [Related]
6. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159 [TBL] [Abstract][Full Text] [Related]
7. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
8. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938 [TBL] [Abstract][Full Text] [Related]
9. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
10. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631 [TBL] [Abstract][Full Text] [Related]
11. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
12. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA; Neel HB; Strome SE; Roche P Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237 [TBL] [Abstract][Full Text] [Related]
13. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731 [TBL] [Abstract][Full Text] [Related]
14. Melanoma gene expression and clinical course. Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132 [TBL] [Abstract][Full Text] [Related]
15. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. Söling A; Schurr P; Berthold F Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332 [TBL] [Abstract][Full Text] [Related]
17. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer. Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma. Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626 [TBL] [Abstract][Full Text] [Related]
19. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257 [TBL] [Abstract][Full Text] [Related]